
Family & sports person. Biostatistician for @roche in @BaselStadt. @numbersman77@mstdn.science
Meiringen, Schweiz
Joined July 2017
- Tweets380
- Following638
- Followers731
- Likes215
1) Why do we run group-sequential trials in drug development?
2) How does the effect we power at relate to the effect(s) needed to stop?
3) Is stopping such a trial early (like the one for the Pfizer vaccine) "cheating"?
Ever planned RCT w/ PFS and OS as formal endpoints?
Ever simulated PFS and OS for same set of patients?
In both cases: How did you model the fact that PFS and OS are highly dependent? E.g. we know that PFS <= OS and P(PFS = OS) > 0.
A (long) thread - but it' s worth it!
1/n
R package provides easily accessible implementation.
Curious to hear comments!
#oncology #multistate #survivalanalysis #biostatistics
Link to paper: arxiv.org/abs/2301.10059
Link to R package: cran.r-project.org/web/packa…
The end.
Link to R package on github: github.com/insightsengineeri…
168
1/2 Upcoming seminar of the Basel Biometric Society:
Quantification of risk: ask the right questions or time to apply the estimand framework to safety!
Speakers from industry + regulators will give overview of current thinking and share recent development in safety evaluation.
1
6
972
2/2 The event will take place on the afternoon of 12th April in a hybrid format, with face-to-face attendance on Novartis Campus in Basel.
Agenda: baselbiometrics.github.io/ho…
Registration: docs.google.com/forms/d/e/1F…
Please RT!
3
352
1/3
Time to bust some myths about use of R and open source software in general for submissions to the FDA!
When I joined pharma in 2012 I admit I was surprised about how inert pharma reporting systems were, and how little was made use of capabilities such as, e.g., R, sweave,
1
8
2/3
and later markdown. I am impressed to see how over time capabilities have been recognized and that several companies invested a massive effort into rebuilding the entire reporting pipeline up to regulatory submissions.
1
2
3/3
I am proud to work for a company that is spearheading these efforts.
linkedin.com/feed/update/urn…
Same here: @numbersman77@mstdn.science
This Post is from an account that no longer exists. Learn more
1
Kaspar Rufibach retweeted
We are very excited about our awesome keynote speakers for #rinpharma Nov 8-10 @sciencealice (pathos.com), Catherine Igartua (@TempusLabs), Robert Gentleman (@harvardmed) & Ross Farrugia (@Roche)!
hopin.com/events/r-pharma-20…
#rstats #pharmaverse #OpenScience #opensource
Roche is looking for statisticians in clinical development in Basel. Come work with us - @Roche is a great company to work for (I have been there for >10y and still very happy!) and we are a cool bunch of folks in Basel!
linkedin.com/jobs/view/32284…


